Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New biobank aims to unlock secrets of pancreatic cancer in diverse populations

NCT ID NCT03851133

Knowledge-focused Sponsor: H. Lee Moffitt Cancer Center and Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a biobank—a collection of blood, tumor tissue, and health data—from 500 people with pancreatic cancer. Researchers want to learn why some groups are affected more than others and how cachexia (severe weight loss) develops. Participants donate samples and fill out questionnaires over a year, but no new treatments are tested.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this biobank could help researchers find better ways to personalize care and reduce health disparities for pancreatic cancer patients.
What could go wrong
This is an observational study, not a treatment trial. It collects data and samples but does not test a therapy, so it won't directly improve survival or symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

500 people

The number who actually took part.

Started

Mar 2019

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients presenting at any of the participating sites with a diagnosis or suspicion or pancreatic cancer

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older. * Patient presents for evaluation at a participating site with a strong clinical suspicion or diagnosis of a pancreatic cancer primary based on symptoms, imaging, biopsy, and/or blood-work and has not had treatment. * Patient self-reports as Non-Hispanic White, African American, or Hispanic. * Able to understand and voluntarily sign the informed consent. * Willing to complete study questionnaire(s) and donate medical images and biological specimens (including tissue and blood) obtained at the time of standard of care procedures (biopsy, surgery, and/or venipuncture) after signing the informed consent document. Exclusion Criteria: * No suspicion or diagnosis of pancreatic cancer. * Has a diagnosis of pancreatic cancer but and has already undergone treatment (which may include surgery, chemotherapy, and/or radiation). * Self-reported race/ethnicity other than Non-Hispanic White, African American, or Hispanic. * Unable to provide informed consent. * Unwilling to complete study questionnaires(s) and/or donate biological specimens

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer cachexia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer cachexia Pancreatic cancer

Contacts and locations

Locations

  • Advent Health - Orlando

    Orlando, Florida, 32804, United States

  • H Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida, 33612, United States

  • Lakeland Regional Health

    Lakeland, Florida, 33805, United States

  • Lee Memorial Hospital Regional Cancer Center

    Fort Myers, Florida, 33905, United States

  • Mount Sinai Medical Center

    Miami Beach, Florida, 33140, United States

  • Palmetto General Hospital

    Hialeah, Florida, 33016, United States

  • Sarasota Memorial Hospital

    Sarasota, Florida, 34239, United States

  • St Anthony's Baycare/Bay Surgical Specialists

    St. Petersburg, Florida, 33705, United States

  • Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital

    Miami, Florida, 33136, United States

  • Tallahassee Memorial Healthcare

    Tallahassee, Florida, 32308, United States

  • University of Florida - Gainesville

    Gainesville, Florida, 32610-0109, United States

  • University of Florida - Jacksonville

    Jacksonville, Florida, 32209, United States

  • University of Florida - Orlando

    Orlando, Florida, 32806, United States

  • University of South Florida/Tampa General Hospital

    Tampa, Florida, 33606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.